SGHT
Sight Sciences, Inc.$4.33+0.01 (+0.12%)Prev Close$4.32·MCap$216.2M·P/E—·Vol68.3K·Yield—
▲
Buys (12M)
4
$1.33M
▼
Sells (12M)
27
$1.97M
◆
Net Activity
Net Seller
$641.2K
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Sight Sciences, Inc. (SGHT) has been mixed between buying and selling, with 4 insider purchases totaling $1.33M and 27 insider sales totaling $1.97M. The most recent insider transaction was by HAYDEN JEREMY B. (officer: Chief Legal Officer), who sold $48.9K worth of shares on Apr 9, 2026. Sight Sciences, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $216.2M.
SGHT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | HAYDEN JEREMY B. | officer: Chief Legal Officer | Sell | 13,761 | $3.55 | $48.9K | 369,770 |
| Apr 9, 2026 | Rodberg James | officer: Chief Financial Officer | Sell | 7,231 | $3.55 | $25.7K | 230,939 |
| Jan 21, 2026 | Badawi David | director, officer: Chief Technology Officer | Sell | 4,836 | $6.62 | $32.0K | 1,912,273 |
| Jan 21, 2026 | Badawi Paul | director, 10 percent owner, officer: President and CEO | Sell | 22,362 | $6.62 | $148.0K | 6,025,840 |
| Jan 16, 2026 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 6,308 | $6.62 | $41.8K | 0 |
| Jan 16, 2026 | Rodberg James | Chief Financial Officer | Sell | 2,616 | $6.62 | $17.3K | 0 |
| Jan 6, 2026 | Taylor Brenton | EVP, Operations & R&D | Sell | 619 | $7.48 | $4.6K | 0 |
| Jan 5, 2026 | Bauerlein Alison | Chief Operating Officer | Sell | 20,543 | $7.66 | $157.4K | 0 |
| Jan 5, 2026 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 11,170 | $7.77 | $86.7K | 0 |
| Jan 5, 2026 | Rodberg James | Chief Financial Officer | Sell | 4,999 | $7.78 | $38.9K | 0 |
| Jan 2, 2026 | Badawi David | Chief Technology Officer | Sell | 9,660 | $7.57 | $73.1K | 0 |
| Jan 2, 2026 | Badawi Paul | President and CEO | Sell | 37,226 | $7.45 | $277.2K | 0 |
| Dec 16, 2025 | Encrantz Staffan | Director | Buy | 13,958 | $8.31 | $116.0K | 0 |
| Dec 2, 2025 | Rodberg James | Chief Financial Officer | Sell | 2,518 | $8.25 | $20.8K | 0 |
| Nov 25, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 44,850 | $8.08 | $362.4K | 0 |
| Nov 17, 2025 | Taylor Brenton | EVP, Operations & R&D | Sell | 14,418 | $7.06 | $101.8K | 0 |
| Nov 12, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 3,150 | $8.01 | $25.2K | 0 |
| Oct 6, 2025 | Taylor Brenton | EVP, Operations & R&D | Sell | 591 | $3.37 | $2.0K | 0 |
| Oct 3, 2025 | Badawi David | Chief Technology Officer | Sell | 6,033 | $3.27 | $19.7K | 0 |
| Oct 3, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,731 | $3.27 | $31.8K | 0 |
| Oct 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,948 | $3.30 | $65.8K | 0 |
| Oct 1, 2025 | Badawi Paul | President and CEO | Sell | 24,441 | $3.34 | $81.6K | 0 |
| Jul 3, 2025 | Badawi David | Chief Technology Officer | Sell | 5,679 | $4.17 | $23.7K | 0 |
| Jul 3, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,160 | $4.17 | $38.2K | 0 |
| Jul 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,260 | $4.10 | $78.9K | 0 |
| Jul 2, 2025 | Link Matthew | Chief Commercial Officer | Sell | 4,889 | $4.10 | $20.0K | 0 |
| Jul 1, 2025 | Badawi Paul | President and CEO | Sell | 23,637 | $4.15 | $98.1K | 0 |
| Jun 4, 2025 | Encrantz Staffan | Director | Buy | 90,525 | $4.22 | $382.0K | 0 |
| May 30, 2025 | Encrantz Staffan | Director | Buy | 98,782 | $3.81 | $376.4K | 0 |
| May 27, 2025 | Encrantz Staffan | Director | Buy | 128,189 | $3.52 | $451.7K | 0 |
| May 19, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 13,066 | $3.48 | $45.4K | 0 |
| Apr 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,397 | $2.31 | $44.8K | 0 |
| Apr 2, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,395 | $2.31 | $21.7K | 0 |
| Apr 2, 2025 | Link Matthew | Chief Commercial Officer | Sell | 5,042 | $2.31 | $11.6K | 0 |
| Apr 1, 2025 | Badawi David | Chief Technology Officer | Sell | 5,980 | $2.30 | $13.8K | 0 |
| Apr 1, 2025 | Badawi Paul | President and CEO | Sell | 24,174 | $2.30 | $55.7K | 0 |
| Mar 11, 2025 | Raheja Manohar K. | EVP, Research & Development | Buy | 20,000 | $2.66 | $53.3K | 0 |
| Jan 21, 2025 | Badawi David | Chief Technology Officer | Sell | 5,423 | $2.78 | $15.1K | 1,744,118 |
| Jan 21, 2025 | Badawi Paul | President and CEO | Sell | 24,819 | $2.92 | $72.6K | 5,676,331 |
| Jan 21, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 6,922 | $2.78 | $19.3K | 145,091 |
| Jan 10, 2025 | Badawi David | Chief Technology Officer | Sell | 3,829 | $3.26 | $12.5K | 1,749,541 |
| Jan 10, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 1,810 | $3.26 | $5.9K | 152,013 |
| Jan 6, 2025 | Badawi David | Chief Technology Officer | Sell | 3,111 | $3.52 | $11.0K | 1,753,370 |
| Jan 6, 2025 | Badawi Paul | President and CEO | Sell | 12,236 | $3.60 | $44.0K | 5,713,197 |
| Jan 6, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 10,102 | $3.52 | $35.6K | 382,453 |
| Jan 6, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 4,864 | $3.52 | $17.1K | 153,823 |
| Dec 9, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 5,000 | $3.85 | $19.3K | 111,000 |
| Dec 5, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 3,376 | $3.89 | $13.1K | 106,000 |
| Dec 3, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 4,624 | $3.99 | $18.4K | 102,624 |
| Nov 21, 2024 | Encrantz Staffan | Buy | 551,802 | $3.73 | $2.06M1.0% OS | 4,573,920 |
Showing 1–50 of 86
1 / 2
SGHT Insider Buying Activity
The following table shows recent insider purchases of Sight Sciences, Inc. (SGHT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Encrantz Staffan | Director | Buy | 13,958 | $8.31 | $116.0K | 0 |
| Jun 4, 2025 | Encrantz Staffan | Director | Buy | 90,525 | $4.22 | $382.0K | 0 |
| May 30, 2025 | Encrantz Staffan | Director | Buy | 98,782 | $3.81 | $376.4K | 0 |
| May 27, 2025 | Encrantz Staffan | Director | Buy | 128,189 | $3.52 | $451.7K | 0 |
| Mar 11, 2025 | Raheja Manohar K. | EVP, Research & Development | Buy | 20,000 | $2.66 | $53.3K | 0 |
| Dec 9, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 5,000 | $3.85 | $19.3K | 111,000 |
| Dec 5, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 3,376 | $3.89 | $13.1K | 106,000 |
| Dec 3, 2024 | Raheja Manohar K. | EVP, Research & Development | Buy | 4,624 | $3.99 | $18.4K | 102,624 |
| Nov 21, 2024 | Encrantz Staffan | Buy | 551,802 | $3.73 | $2.06M1.0% OS | 4,573,920 |
SGHT Insider Selling Activity
The following table shows recent insider sales of Sight Sciences, Inc. (SGHT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | HAYDEN JEREMY B. | officer: Chief Legal Officer | Sell | 13,761 | $3.55 | $48.9K | 369,770 |
| Apr 9, 2026 | Rodberg James | officer: Chief Financial Officer | Sell | 7,231 | $3.55 | $25.7K | 230,939 |
| Jan 21, 2026 | Badawi David | director, officer: Chief Technology Officer | Sell | 4,836 | $6.62 | $32.0K | 1,912,273 |
| Jan 21, 2026 | Badawi Paul | director, 10 percent owner, officer: President and CEO | Sell | 22,362 | $6.62 | $148.0K | 6,025,840 |
| Jan 16, 2026 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 6,308 | $6.62 | $41.8K | 0 |
| Jan 16, 2026 | Rodberg James | Chief Financial Officer | Sell | 2,616 | $6.62 | $17.3K | 0 |
| Jan 6, 2026 | Taylor Brenton | EVP, Operations & R&D | Sell | 619 | $7.48 | $4.6K | 0 |
| Jan 5, 2026 | Bauerlein Alison | Chief Operating Officer | Sell | 20,543 | $7.66 | $157.4K | 0 |
| Jan 5, 2026 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 11,170 | $7.77 | $86.7K | 0 |
| Jan 5, 2026 | Rodberg James | Chief Financial Officer | Sell | 4,999 | $7.78 | $38.9K | 0 |
| Jan 2, 2026 | Badawi David | Chief Technology Officer | Sell | 9,660 | $7.57 | $73.1K | 0 |
| Jan 2, 2026 | Badawi Paul | President and CEO | Sell | 37,226 | $7.45 | $277.2K | 0 |
| Dec 2, 2025 | Rodberg James | Chief Financial Officer | Sell | 2,518 | $8.25 | $20.8K | 0 |
| Nov 25, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 44,850 | $8.08 | $362.4K | 0 |
| Nov 17, 2025 | Taylor Brenton | EVP, Operations & R&D | Sell | 14,418 | $7.06 | $101.8K | 0 |
| Nov 12, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 3,150 | $8.01 | $25.2K | 0 |
| Oct 6, 2025 | Taylor Brenton | EVP, Operations & R&D | Sell | 591 | $3.37 | $2.0K | 0 |
| Oct 3, 2025 | Badawi David | Chief Technology Officer | Sell | 6,033 | $3.27 | $19.7K | 0 |
| Oct 3, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,731 | $3.27 | $31.8K | 0 |
| Oct 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,948 | $3.30 | $65.8K | 0 |
| Oct 1, 2025 | Badawi Paul | President and CEO | Sell | 24,441 | $3.34 | $81.6K | 0 |
| Jul 3, 2025 | Badawi David | Chief Technology Officer | Sell | 5,679 | $4.17 | $23.7K | 0 |
| Jul 3, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,160 | $4.17 | $38.2K | 0 |
| Jul 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,260 | $4.10 | $78.9K | 0 |
| Jul 2, 2025 | Link Matthew | Chief Commercial Officer | Sell | 4,889 | $4.10 | $20.0K | 0 |
| Jul 1, 2025 | Badawi Paul | President and CEO | Sell | 23,637 | $4.15 | $98.1K | 0 |
| May 19, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 13,066 | $3.48 | $45.4K | 0 |
| Apr 2, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 19,397 | $2.31 | $44.8K | 0 |
| Apr 2, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9,395 | $2.31 | $21.7K | 0 |
| Apr 2, 2025 | Link Matthew | Chief Commercial Officer | Sell | 5,042 | $2.31 | $11.6K | 0 |
| Apr 1, 2025 | Badawi David | Chief Technology Officer | Sell | 5,980 | $2.30 | $13.8K | 0 |
| Apr 1, 2025 | Badawi Paul | President and CEO | Sell | 24,174 | $2.30 | $55.7K | 0 |
| Jan 21, 2025 | Badawi David | Chief Technology Officer | Sell | 5,423 | $2.78 | $15.1K | 1,744,118 |
| Jan 21, 2025 | Badawi Paul | President and CEO | Sell | 24,819 | $2.92 | $72.6K | 5,676,331 |
| Jan 21, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 6,922 | $2.78 | $19.3K | 145,091 |
| Jan 10, 2025 | Badawi David | Chief Technology Officer | Sell | 3,829 | $3.26 | $12.5K | 1,749,541 |
| Jan 10, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 1,810 | $3.26 | $5.9K | 152,013 |
| Jan 6, 2025 | Badawi David | Chief Technology Officer | Sell | 3,111 | $3.52 | $11.0K | 1,753,370 |
| Jan 6, 2025 | Badawi Paul | President and CEO | Sell | 12,236 | $3.60 | $44.0K | 5,713,197 |
| Jan 6, 2025 | Bauerlein Alison | Chief Financial Officer | Sell | 10,102 | $3.52 | $35.6K | 382,453 |
| Jan 6, 2025 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 4,864 | $3.52 | $17.1K | 153,823 |
SGHT Insiders
Similar Stocks to SGHT
ABT
Abbott Laboratories
$93.69+0.96%
$166.85B
SYK
Stryker Corporation
$322.18-2.10%
$129.58B
BSX
Boston Scientific Corporation
$58.27-2.81%
$90.64B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$287.57+0.00%
$47.35B
EW
Edwards Lifesciences Corporation
$81.98-1.79%
$47.30B
DXCM
DexCom, Inc.
$59.85-2.56%
$24.16B
ZBH
Zimmer Biomet Holdings, Inc.
$82.15-11.37%
$18.14B
ALGN
Align Technology, Inc.
$176.34-4.53%
$13.98B